NEWS
Solving the RNase crossword puzzle using pre- and post-column digestion
An mRNA mapping brainteaser: solving the RNase crossword puzzle using pre- and post-column digestion As mRNA therapeutics and vaccines move from promise to mainstream medicine, the analyti [...]
Miniaturized HPAC-MS: Turning Antigen Binding into a Functional Separation Dimension for mAbs
Miniaturized HPAC-MS: Turning Antigen Binding into a Functional Separation Dimension for mAbs Knowing what a monoclonal antibody (mAb) is made of is only half the picture. What ultimately [...]
Unravelling Peptide Therapeutics: From Molecular Design to Lifecycle‑Ready Analytics
Unravelling Peptide Therapeutics: From Molecular Design to Lifecycle‑Ready Analytics Peptide therapeutics have evolved from early biological curiosities into one of the most dynamic and co [...]
Unravelling Biologics: How Multi-Dimensional LC-MS is Changing the Game
Unravelling Biologics: How Multi-Dimensional LC-MS is Changing the Game Biopharmaceuticals such as monoclonal antibodies and therapeutic enzymes are molecular giants, highly heterogeneous [...]
RIC group has renewed its CIR (Credit d’Impôt Recherche) certificate until 2026
RIC group has renewed its CIR (Credit d'Impôt Recherche) certificate until 2026 The research tax credit (CIR) is a tax system to support the research and development (R&D) activities [...]
ONA Therapeutics, Absolute Antibody and RIC partner to create new type of biologic
ONA Therapeutics, Absolute Antibody and RIC partner to create new type of biologic ONA Therapeutics, Absolute Antibody and RIC - three leading European companies in the biotech landscape [...]
